Profil
David Caouette is currently the Vice President-Corporate Communications at Seagen Inc. He previously worked as the Head-Media Relations at Merck & Co., Inc. and Biogen, Inc.
Aktive Positionen von David Caouette
| Unternehmen | Position | Beginn |
|---|---|---|
| SEAGEN INC. | Public Communications Contact | 01.06.2021 |
Ehemalige bekannte Positionen von David Caouette
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Public Communications Contact | 01.05.2021 |
| MERCK & CO., INC. | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
